Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.

P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Med Oncol. 2013; 30(2):567.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.